I.D.E.A. Ltd. - Innovative Drugs European Associates

Organisation

I.D.E.A. Ltd. centralises all the information of all studies running in any of the 25 European Union plus other countries satellite to the EU that may be used in your trial. A comprehensive and consistent approach to adverse event reporting is applied based on the legal requirements and incorporates industry best practices.

Consistency of service and approach is ensured by the assignment of the Chief Regulatory Officer to a specific project or project/company. He remains the main contact with the sponsor for the duration of the trial and thereafter for any necessary follow-up activities, for example adverse events. The operation offers 24 hours coverage.

I.D.E.A. can represent you in all 25 countries of the European Union

Austria

Belgium

Cyprus

Czech Rep.

Denmark

Estonia

Finland

France

Germany

Greece

Hungary

Ireland

Italy

Latvia

Lithuania

Luxembourg

Malta

Netherlands

Poland

Portugal

Slovakia

Slovenia

Spain

Sweden

United Kingdom

Norway, Iceland, Switzerland and Liechtenstein

Although not EU member states, Norway and Iceland have implemented the EU Clinical Trials Directive and Switzerland and Lichtenstein observe most EU regulations.

Norway

Iceland

Switzerland

Liechtenstein